NDAORALSOLUTION
Approved
Oct 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
3/8 — Basic
Drug data last refreshed Just now · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SOLTAMOX (tamoxifen citrate) is an oral solution formulation of tamoxifen, a selective estrogen receptor modulator (SERM) used primarily in breast cancer treatment and prevention. The drug works by blocking estrogen receptors on cancer cells, inhibiting their growth and survival. It represents a foundational hormonal therapy option for estrogen receptor-positive breast cancer patients.
$0.469MPart D
LOE ApproachingDeclining
Limited commercial expansion opportunity; brand team likely focuses on maximizing remaining patent life and managing transition to generic competition.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
Started Sep 2010
84 enrolled
Breast Cancer
Career Relevance
SOLTAMOX offers limited career development given its LOE-approaching status and minimal linked job openings. Roles on this product are primarily focused on efficient brand management and generic transition support rather than growth initiatives. Career advancement would require lateral movement to growth-stage products within the PharmaIN portfolio.
Brand Manager
Worked on SOLTAMOX at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.